Who is sponsoring NCT05276518?

NCT05276518 is sponsored by Ain Shams Maternity Hospital.

What drugs are being tested in NCT05276518?

Interventions in NCT05276518: Closure of cesarean section incision.

What condition does NCT05276518 study?

NCT05276518 studies Cesarean Scar Defect.

Is NCT05276518 still recruiting?

NCT05276518 is currently status unknown. Last updated 16 August 2022.

Last reviewed 2022-08-16 · How we verify

NCT05276518

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double Vers Single in Cesarean Incision

Status unknown Last updated 16 August 2022

What this trial tests

trial testing Closure of cesarean section incision in Cesarean Scar Defect in 60 participants. Status unknown.

Timeline

20 April 2022

Primary endpoint
20 October 2022

1 April 2023

Quick facts

Lead sponsor	Ain Shams Maternity Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	20 April 2022
Primary completion	20 October 2022
Estimated completion	1 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

Closure of cesarean section incision

Conditions studied

Cesarean Scar Defect — all drugs for Cesarean Scar Defect →

Sponsor

Ain Shams Maternity Hospital

Who can join

Adults 16 to 50, female only, with Cesarean Scar Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the effect of single versus double layer closure of caesarean scar on the residual myometrium on the short \& intermediate term.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

NCT07514078 — Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer · NA · not yet recruiting
NCT07308977 — Practice of Assisted Vaginal Birth in Egypt · not yet recruiting
NCT06935422 — Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complic · recruiting
NCT06524700 — Pectopexy Autologous Vs Mesh · NA · active not recruiting
NCT07247851 — Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05276518 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams Maternity Hospital
Last refreshed: 16 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing